Literature DB >> 3697926

Risk of second cancer after cancer in childhood.

J H Olsen.   

Abstract

Against the background of a seemingly short latency period for the majority of childhood tumors and the theory of the existence of a prezygotic variation of the two-step mutation model prior to tumor development, the risk of second cancer after cancer in childhood is examined in the population of Denmark from 1943-1980. A total of 5319 cases of primary cancer in childhood were followed until patient death or the end of 1980, and the number of secondary tumors were observed, specifying on diagnosis, age, sex, and time since first tumor diagnosis. A total of 23 secondary tumors was observed (O) against an expected (E) figure of 6.5, corresponding to an O/E ratio of 4.4. The risk varies greatly according to time elapsed since first diagnosis, with the highest risk in close relation to the primary tumor. The second tumor is probably more frequently localized to the skin and brain than elsewhere, and the risk of a second tumor is particularly associated with leukemia and osteosarcoma in childhood. It is concluded that the results are compatible with the theory of a prezygotic variation of the two-step mutation model.

Entities:  

Mesh:

Year:  1986        PMID: 3697926     DOI: 10.1002/1097-0142(19860601)57:11<2250::aid-cncr2820571131>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries.

Authors:  J H Olsen; S Garwicz; H Hertz; G Jonmundsson; F Langmark; M Lanning; S O Lie; P J Moe; T Møller; R Sankila
Journal:  BMJ       Date:  1993-10-23

2.  Long-term risk of second malignant neoplasm after a cancer in childhood.

Authors:  F de Vathaire; O Schweisguth; C Rodary; P François; D Sarrazin; O Oberlin; C Hill; M A Raquin; A Dutreix; R Flamant
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

3.  Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.

Authors:  Xiaofei Mo; Mingge Zhou; Hui Yan; Xueqin Chen; Yuetao Wang
Journal:  Cancer Med       Date:  2021-06-29       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.